Acadia Pharma (ACAD) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $25.32 +6.75%
EPS Growth %: -62.5%
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -62.5%
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q3 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- UBS Downgrades Grand Korea Leisure (114090:KS) to Neutral
- Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
